References
- Lorence A, Medina-Bolivar F, Nessler CL. Camptothecin and 10-hydroxycamptothecin from Camptotheca acuminata hairy roots. Plant Cell Rep 2004;22:437–431.
- Jaxel C, Kohn KW, Wani MC, Wall ME, Pommier Y. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: Evidence for a specific receptor site and a relation to antitumor activity. Cancer Res 1989;49:1465–1469.
- Garcia-Carbonero R, Supko JG. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res 2002;8:641–661.
- Slichenmyer WJ, Rowinsky EK, Donehower RC, Kaufmann SH. The current status of camptothecin analogues as antitumor agents. J Nat Cancer Inst 1993;85:271–291.
- Chourpa I, Millot JM, Sockalingum GD, Riou JF, Manfait M. Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Biochim Biophys Acta 1998;1379:353–366.
- O’Leary J, Muggia FM. Camptothecins: A review of their development and schedules of administration. Eur J Cancer 1998;34:1500–1508.
- Dancey J, Eisenhauer EA. Current perspective on campothecins in cancer treatment. Br J Cancer 1996;74:327–338.
- Gabizon A. Liposome as drug carriers: Recent trends and progress. In:Roerdink FHD, Kroo AM, editors. Drug carrier system. Chichester: Wiley: 1989;185–211.
- Zhang JA, Xuan T, Parmar M, Ma L, Ugwu S, Ali S, Ahmad I. Development and characterization of a novel liposome-based formulation of SN-38. Int J Pharm 2004;270:93–107
- Koshkina NV, Kleinerman ES, Waidrep C, Jia SF, Worth LL, Gilbert BE, Knight V. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice. Clin Cancer Res 2000;6:2876–2880.
- New RRC. Liposomes: A practical approach. Oxford: IRL Press. 1990;256–258.
- Baca-Estrada ME, Foldvari MM, Snider MM, Harding KK, Kournikakis BB, Babiuk LA, Griebel PP. Intranasal immunization with liposome-formulated Yersinia pestis vaccine enhances mucosal immune responses. Vaccine 2000;18:2203–2211.
- Fassberg J, Stella VJ. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J Pharm Sci 1992;81:676–684.
- Venkateswarlu V, Manjunath K. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J Control Release 2004;95:627–638.
- Supko JG, Malspeis L. A reversed-phase HPLC method for determining camptothecin in plasma with specificity for the intact lactone form of the drug. J Liq Chromatogr 1991;14:1779–1803.
- Shenderova TGB, Schwendeman SP. Stabilization of 10-hydrocamptothecin in poly(lactide-co-glycolide) microsphere delivery vehicles. Pharm Res 1997;14:1406–1414.
- Gutknecht J, Walter A. Hydroxyl ion permeability of lipid bilayer membranes. Biochim Biophys Acta 1981;81:161–162
- Lewis BA, Engelman DM. Lipid bilayer thickness varies linearly with acyl chain length in fluid phosphatidylcholine vesicles. J Mol Biol 1983;166:211–217.
- Li YF, Zhang R. Reversed-phase high-performance liquid chromatography method for the simultaneous quantitation of the lactone and carboxylate forms of the novel natural product anticancer agent 10-hydroxycamptothecin in biological fluids and tissues. J Chromatogr B. Biomed Appl 1996;686:257–265.
- Patel HM, Moghimi SM. Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system – the concept of tissue specificity. Adv Drug. Deliv Rev 1998;32:45–60.
- Burke TG, Mi Z. The structural basis of camptothecin interactions with human serum albumin: Impact on drug stability. J Med Chem 1994;37:40–46.